- Stocks
- Healthcare
- NYSE: DHR

Price (delayed)

$273.09

Market cap

$197.23B

P/E Ratio

47.99

Dividend/share

$1.05

EPS

$5.69

Enterprise value

$211.87B

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's

The debt has declined by 14% year-on-year and by 6% since the previous quarter

The quick ratio has declined by 44% year-on-year and by 37% since the previous quarter

The price to earnings (P/E) is 36% more than the 5-year quarterly average of 35.3 and 26% more than the last 4 quarters average of 38.2

What are the main financial stats of DHR

Market
Valuations
Earnings

Shares outstanding

722.21M

Market cap

$197.23B

Enterprise value

$211.87B

Price to earnings (P/E)

47.99

Price to book (P/B)

4.05

Price to sales (P/S)

9.54

EV/EBIT

42.1

EV/EBITDA

29.24

EV/Sales

10.04

Revenue

$21.11B

EBIT

$5.03B

EBITDA

$7.25B

Free cash flow

$5.11B

Per share
Balance sheet
Liquidity

EPS

$5.69

Free cash flow per share

$6.93

Book value per share

$67.37

Revenue per share

$28.61

TBVPS

$24.68

Total assets

$78.56B

Total liabilities

$28.65B

Debt

$17.01B

Equity

$49.9B

Working capital

$2.91B

Debt to equity

0.34

Current ratio

1.43

Quick ratio

0.85

Net debt/EBITDA

2.02

Margins
Efficiency
Dividend

EBITDA margin

34.3%

Gross margin

59.4%

Net margin

19.9%

Operating margin

21.1%

Return on assets

5%

Return on equity

8%

Return on invested capital

18.5%

Return on capital employed

7%

Return on sales

23.8%

Dividend yield

0.38%

DPS

$1.05

Payout ratio

18.5%

How has the Danaher stock price performed over time

Intraday

2.59%

1 week

1.4%

1 month

1.86%

1 year

9.96%

YTD

18.05%

QTD

9.3%

How have Danaher's revenue and profit performed over time

Revenue

$21.11B

Gross profit

$12.54B

Operating income

$4.46B

Net income

$4.2B

Gross margin

59.4%

Net margin

19.9%

The net income has declined by 34% year-on-year and by 4.5% since the previous quarter

The net margin has declined by 28% year-on-year and by 3.9% since the previous quarter

Danaher's operating income has decreased by 24% YoY

DHR's operating margin is down by 17% YoY

What is Danaher's growth rate over time

What is Danaher stock price valuation

P/E

47.99

P/B

4.05

P/S

9.54

EV/EBIT

42.1

EV/EBITDA

29.24

EV/Sales

10.04

The price to earnings (P/E) is 36% more than the 5-year quarterly average of 35.3 and 26% more than the last 4 quarters average of 38.2

DHR's EPS is down by 34% year-on-year and by 4.5% since the previous quarter

The P/B is 16% more than the last 4 quarters average of 3.5 and 3.8% more than the 5-year quarterly average of 3.9

The equity has contracted by 7% from the previous quarter and by 3.5% YoY

DHR's P/S is 29% above its 5-year quarterly average of 7.4 and 16% above its last 4 quarters average of 8.2

Danaher's revenue has decreased by 8% YoY

How efficient is Danaher business performance

Danaher's ROE has decreased by 37% YoY and by 3.6% from the previous quarter

DHR's ROA is down by 33% year-on-year and by 3.8% since the previous quarter

The return on invested capital has declined by 23% year-on-year and by 2.1% since the previous quarter

DHR's return on sales is down by 23% year-on-year and by 4% since the previous quarter

What is DHR's dividend history

DPS

$1.05

Dividend yield

0.38%

Payout ratio

18.5%

Recent dividends

Special dividends are included in TTM DPS and yield

How did Danaher financials performed over time

The total assets is 174% greater than the total liabilities

The quick ratio has declined by 44% year-on-year and by 37% since the previous quarter

The current ratio has declined by 31% year-on-year and by 23% since the previous quarter

The debt is 66% smaller than the equity

The debt has declined by 14% year-on-year and by 6% since the previous quarter

Danaher's debt to equity has decreased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.